Akari Therapeutics Plc - Filer Information

Symbol
AKTX on Nasdaq
Entity
Company
CIK
0001541157
EIN
981034922
Business address
22 Boston Wharf Road, Fl 7, 02210 Boston, MA
Phone
(646) 350-0702
State of incorporation
United Kingdom
Category
Non-accelerated filer
Smaller reporting company
Former names
Celsus Therapeutics Plc. (to 9/15/2015), Morria Biopharmaceuticals PLC (to 6/20/2013)
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company